The clinical significance of B-cell maturation antigen as a therapeutic target and biomarker-Reference-Cited by-同舟云学术

The clinical significance of B-cell maturation antigen as a therapeutic target and biomarker

Published:2018-03-07 Issue:4 Volume:18 Page:319-329
ISSN:1473-7159
Container-title:Expert Review of Molecular Diagnostics
language:en
Short-container-title:Expert Review of Molecular Diagnostics

Author:

Sanchez Eric¹,Tanenbaum Edward J.¹,Patil Saurabh¹,Li Mingjie¹,Soof Camilia M.¹,Vidisheva Aleksandra²,Waterman Gabriel N.³,Hekmati Tara¹,Tang George¹,Wang Cathy S.¹,Chen Haiming¹,Berenson James¹

Affiliation:

1. Institute for Myeloma and Bone Cancer Research (IMBCR), West Hollywood, CA, USA

2. University of Arizona College of Medicine - Tucson, Tucson, AZ, USA

3. Keck School of Medicine, University of Southern California - Los Angeles, Los Angeles, CA, USA

Funder

not funded

Publisher

Informa UK Limited

Subject

Genetics,Molecular Biology,Molecular Medicine,Pathology and Forensic Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737159.2018.1448269

Reference44 articles.

1. A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a t(4;16)(q26;p13) translocation in a malignant T cell lymphoma.

2. The BCMA gene, preferentially expressed during B lymphoid maturation, is bidirectionally transcribed

3. Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival

4. Baff Binds to the Tumor Necrosis Factor Receptor–Like Molecule B Cell Maturation Antigen and Is Important for Maintaining the Peripheral B Cell Population

5. Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in drugs restructured with nanomedicines for multiple myeloma treatment;Science China Materials;2024-09-10

2. Elevated serum levels of soluble B-cell maturation antigen as a prognostic biomarker for multiple myeloma;Clinical and Experimental Immunology;2024-05-14

3. Broadening the horizon: potential applications of CAR-T cells beyond current indications;Frontiers in Immunology;2023-11-27

4. Moderne Immuntherapie: Update zu Antikörper-Wirkstoff-Konjugaten bei hämatologischen Neoplasien;Antikörper-Wirkstoff-Konjugate;2023-09-26

5. Clinical Outcomes and Serum B-Cell Maturation Antigen Levels in a Real-World Unselected Population of Newly Diagnosed Multiple Myeloma Patients;Targeted Oncology;2023-09